GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · Real-Time Price · USD
0.7680
+0.0070 (0.92%)
At close: Sep 26, 2025, 4:00 PM EDT
0.7760
+0.0080 (1.04%)
After-hours: Sep 26, 2025, 7:59 PM EDT
GT Biopharma Market Cap
GT Biopharma has a market cap or net worth of $2.73 million as of September 26, 2025. Its market cap has decreased by -41.87% in one year.
Market Cap
2.73M
Enterprise Value
-2.50M
1-Year Change
-41.87%
Ranking
Category
Stock Price
$0.77
Market Cap Chart
Since March 27, 2018, GT Biopharma's market cap has decreased from $83.20M to $2.73M, a decrease of -96.72%. That is a compound annual growth rate of -36.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 2.70M | -60.29% |
| Dec 31, 2024 | 6.80M | -35.85% |
| Dec 29, 2023 | 10.60M | -63.19% |
| Dec 30, 2022 | 28.80M | -69.13% |
| Dec 31, 2021 | 93.30M | 181.02% |
| Dec 31, 2020 | 33.20M | 503.64% |
| Dec 31, 2019 | 5.50M | -83.13% |
| Dec 31, 2018 | 32.60M | -60.82% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 656.99B |
| Johnson & Johnson | 426.40B |
| AbbVie | 390.27B |
| UnitedHealth Group | 313.99B |
| Novo Nordisk | 259.65B |
| Novartis AG | 238.19B |
| AstraZeneca | 233.83B |
| Abbott Laboratories | 229.61B |